Basic Information
RNALocate ID: | RLID:11003781 |
RNA Symbol: | hsa-miR-149-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-149* |
RNA ID: | miRBase:MIMAT0004609 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 20976003 |
Tissue/Cell Line: | Breast cancer cell line (MCF-7) |
Method: | Microarray |
Description: | Because of the suggested roles of extracellular miRNAs in signaling and diagnosis, we investigated whether the intracellular and extracellular miRNA composition are the same. To answer this question, we performed microRNA microarray analyses of MCF7 cellular (c) and extracellular (x) RNAs (Figure 2A), and found that about 66% of the released miRNAs are at an abundance that closely reflects the cellular miRNA abundance (Figures 2B and 2C). This finding is in agreement with a model wherein most, but not all miRNAs are released passively by mass action. Data are collected from Figure 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002607 | Mitochondrion | Cell line (HEK-293) | 22984580 |
RLID:11003782 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11003783 | Exosome | Plasma | 23663360 |
RLID:11003784 | Exosome | K562 cells | 24460325 |
RLID:11003785 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
RLID:11003786 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000639 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001514 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-149-3p | Oral squamous cell carcinoma | MNDR-E-MI-16266 |
MNDR | hsa-miR-149-3p | Medulloblastoma | MNDR-E-MI-16267 |
MNDR | hsa-miR-149-3p | Lymphoma | MNDR-E-MI-16268 |
MNDR | hsa-miR-149-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-16269 |
MNDR | hsa-miR-149-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-16270 |
MNDR | hsa-miR-149-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-16271 |
MNDR | hsa-miR-149-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-16272 |
MNDR | hsa-miR-149-3p | Her2-receptor positive breast cancer | MNDR-E-MI-16273 |
MNDR | hsa-miR-149-3p | Breast cancer luminal | MNDR-E-MI-16274 |
MNDR | hsa-miR-149-3p | Prostate cancer | MNDR-E-MI-16275 |
MNDR | hsa-miR-149-3p | Gastric cancer | MNDR-E-MI-16276 |
MNDR | hsa-miR-149-3p | Intracranial aneurysm | MNDR-E-MI-16277 |
MNDR | hsa-miR-149-3p | Lung cancer | MNDR-E-MI-16278 |
MNDR | hsa-miR-149-3p | Parkinson disease | MNDR-E-MI-16279 |
MNDR | hsa-miR-149-3p | Basal-like breast cancer | MNDR-E-MI-16280 |
MNDR | hsa-miR-149-3p | Pancreatic cancer | MNDR-E-MI-16281 |
MNDR | hsa-miR-149-3p | HCV | MNDR-E-MI-16282 |
MNDR | hsa-miR-149-3p | Nephroblastoma | MNDR-E-MI-16283 |
MNDR | hsa-miR-149-3p | Colon cancer | MNDR-E-MI-16284 |
MNDR | hsa-miR-149-3p | Familial ovarian cancer | MNDR-E-MI-16285 |
MNDR | hsa-miR-149-3p | Glioblastoma | MNDR-E-MI-16286 |
MNDR | hsa-miR-149-3p | Glioma | MNDR-E-MI-16287 |
MNDR | hsa-miR-149-3p | Chordoma | MNDR-E-MI-16288 |
MNDR | hsa-miR-149-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-16289 |
MNDR | hsa-miR-149-3p | Osteosarcoma | MNDR-E-MI-16290 |
MNDR | hsa-miR-149-3p | Breast carcinoma | MNDR-E-MI-16291 |
MNDR | hsa-miR-149-3p | Infarction middle cerebral artery | MNDR-E-MI-16292 |
MNDR | hsa-miR-149-3p | Lung squamous cell carcinoma | MNDR-E-MI-16293 |
MNDR | hsa-miR-149-3p | Lung adenocarcinoma | MNDR-E-MI-16294 |
MNDR | hsa-miR-149-3p | Bladder urothelial carcinoma | MNDR-E-MI-16295 |
MNDR | hsa-miR-149-3p | Cholangiocarcinoma | MNDR-E-MI-16296 |
MNDR | hsa-miR-149-3p | Esophageal cancer | MNDR-E-MI-16297 |
MNDR | hsa-miR-149-3p | Lung small cell carcinoma | MNDR-E-MI-16298 |
MNDR | hsa-miR-149-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-16299 |
MNDR | hsa-miR-149-3p | Hepatocellular carcinoma | MNDR-E-MI-16300 |
MNDR | hsa-miR-149-3p | Familiar ovarian carcinoma | MNDR-E-MI-16301 |
MNDR | hsa-miR-149-3p | Retinoblastoma | MNDR-E-MI-16302 |
MNDR | hsa-miR-149-3p | Neuroblastoma | MNDR-E-MI-16303 |
MNDR | hsa-miR-149-3p | Hodgkin lymphoma | MNDR-E-MI-16304 |
MNDR | hsa-miR-149-3p | Colorectal cancer | MNDR-E-MI-16305 |
MNDR | hsa-miR-149-3p | Nasopharynx carcinoma | MNDR-E-MI-16306 |
MNDR | hsa-miR-149-3p | Nasopharyngeal cancer | MNDR-E-MI-16307 |
MNDR | hsa-miR-149-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-16308 |
MNDR | hsa-miR-149-3p | Stroke lacunar | MNDR-E-MI-16309 |
MNDR | hsa-miR-149-3p | Breast cancer her3+ negative | MNDR-E-MI-16310 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AKT1 | Homo sapiens | RR00066993 |
TOP